Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
NCT06416007 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 37
Last updated 2026-05-04
Summary
The purpose of this research study is to determine if lattice radiation therapy (LRT) will provide better treatment for bulky (large) tumors than current standard of care radiotherapy.
Conditions
- Cancer
- Metastatic Cancer
- Locally Advanced
- Locally Advanced Solid Tumor
- Locally Advanced Carcinoma
Interventions
- RADIATION
-
Lattice therapy (LRT)
5 Fractions LRT
Sponsors & Collaborators
-
University of Cincinnati
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-02
- Primary Completion
- 2027-01-01
- Completion
- 2027-06-01
Countries
- United States
Study Locations
More Related Trials
-
Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Conventional Type Chondrosarcoma
NCT04098887 ·Status: WITHDRAWN ·Phase: NA
-
Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver
NCT01030757 ·Status: TERMINATED ·Phase: PHASE2
-
Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.
NCT04549246 ·Status: COMPLETED
-
NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
NCT02721056 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
NCT01346410 ·Status: COMPLETED ·Phase: NA
-
Individualized Stereotactic Body Radiotherapy of Liver Metastases
NCT01239381 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases
NCT00006255 ·Status: COMPLETED ·Phase: PHASE2
-
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
NCT01586104 ·Status: COMPLETED ·Phase: NA
-
SBRT + TACE for Primary Hepatocellular Carcinoma
NCT00746655 ·Status: WITHDRAWN ·Phase: NA
-
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
NCT00922974 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
NCT04218617 ·Status: RECRUITING ·Phase: PHASE2
-
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
NCT01367301 ·Status: TERMINATED ·Phase: NA
-
A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)
NCT00154817 ·Status: COMPLETED ·Phase: PHASE2
-
Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors
NCT06390657 ·Status: WITHDRAWN
-
LAttice Radiation Therapy for Large Lesions: Reggio Emilia Single-arm Phase II Trial
NCT07000162 ·Status: RECRUITING ·Phase: PHASE2
-
Stereotactic Body Radiotherapy for Liver Tumors
NCT01347333 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy in Treating Patients With Liver Metastases
NCT00255814 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients
NCT06416436 ·Status: WITHDRAWN ·Phase: PHASE1
-
Radiofrequency Ablation in Treating Patients With Bone Metastases
NCT00026247 ·Status: COMPLETED ·Phase: NA
-
Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously
NCT01543672 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SBRT for Extra-cranial Oligorecurrent Tumor
NCT02410187 ·Status: UNKNOWN ·Phase: PHASE2
-
Stereotactic Body Radiotherapy for Spine Tumors
NCT01347307 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer
NCT02206724 ·Status: WITHDRAWN ·Phase: NA
-
Stereotactic Body Radiation Therapy (SBRT) for Patients With Hepatic Metastases
NCT01162278 ·Status: COMPLETED ·Phase: PHASE1
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
NCT07225036 ·Status: RECRUITING ·Phase: NA